mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.5 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |